Voss Capital LP Has $69.83 Million Position in Sotera Health Company $SHC

Voss Capital LP lifted its position in shares of Sotera Health Company (NASDAQ:SHC) by 114.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,958,482 shares of the company’s stock after buying an additional 2,108,482 shares during the period. Sotera Health comprises about 3.4% of Voss Capital LP’s investment portfolio, making the stock its 11th largest holding. Voss Capital LP owned 1.39% of Sotera Health worth $69,828,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. CenterBook Partners LP raised its holdings in Sotera Health by 94.1% during the fourth quarter. CenterBook Partners LP now owns 151,529 shares of the company’s stock worth $2,673,000 after acquiring an additional 73,473 shares in the last quarter. Capricorn Fund Managers Ltd bought a new stake in Sotera Health during the fourth quarter worth about $7,936,000. Nordea Investment Management AB bought a new stake in Sotera Health during the fourth quarter worth about $1,908,000. Exchange Traded Concepts LLC bought a new stake in Sotera Health during the fourth quarter worth about $7,739,000. Finally, Retirement Systems of Alabama raised its holdings in Sotera Health by 16.9% during the fourth quarter. Retirement Systems of Alabama now owns 248,899 shares of the company’s stock worth $4,391,000 after acquiring an additional 35,974 shares in the last quarter. Institutional investors own 91.03% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Weiss Ratings lowered Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Thursday, May 21st. Citigroup upped their target price on Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a report on Tuesday, February 24th. Wall Street Zen lowered Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Piper Sandler restated an “overweight” rating and issued a $22.00 price objective (down from $24.00) on shares of Sotera Health in a research note on Wednesday, May 6th. Finally, The Goldman Sachs Group began coverage on Sotera Health in a research note on Friday, June 5th. They issued a “buy” rating and a $20.00 price objective on the stock. Eight research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $20.29.

Sotera Health Price Performance

NASDAQ:SHC opened at $16.19 on Friday. The company has a quick ratio of 2.54, a current ratio of 2.82 and a debt-to-equity ratio of 3.56. The stock’s 50 day moving average price is $15.61 and its two-hundred day moving average price is $16.38. The firm has a market capitalization of $4.62 billion, a price-to-earnings ratio of 39.49 and a beta of 1.79. Sotera Health Company has a 12-month low of $10.80 and a 12-month high of $19.85.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.01. The firm had revenue of $280.05 million for the quarter, compared to analyst estimates of $270.78 million. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, analysts anticipate that Sotera Health Company will post 0.86 earnings per share for the current year.

Insider Buying and Selling at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total transaction of $193,194,516.17. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 15.36% of the company’s stock.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.